DRKS00003269已完成未知
Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca
niversitätsklinikum Erlangen der Friedrich-Alexander Universität Erlangen-Nürnberg0 个研究点目标入组 62 人开始时间: 2011年10月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 62
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •patients with severe keratoconjunctivitis sicca (Dry Eye Severity Level 3, Dry eye severity grading scheme, DEWS 2007); age between 18 and 75 years; education and written consent; severe symptoms; positive staining in fluorescein and rose bengal staining
排除标准
- •pregnancy; breast feeding mothers; other ocular diseases that demand other topical medicatios (anti-glaucoma eye drops); lidanomalies; insufficiency of eyelid closure; ocular surgery within the previous 3 months, especially after refractive surgery or cataract surgery; wearing of contact lenses; systemic or topical application of corticosteroids; uveitis anterior; ocular pemphigoid; Stevens-Johnson-Syndrome; ocular burns; no compliance; underaged patients; written consent not possible
研究者
相似试验
招募中
3 期
Topical cyclosporine 0.05% impact on pterygium recurrence in patients undergoing pterygium surgeryIRCT20160919029871N4Guilan University Of Medical Sciences74
已完成
不适用
The efficacy of 0.05% cyclosporin eye drop for dry eye diseaseDiseases of the eye and adnexaKCT0006923Pusan National University Hospital64
进行中（未招募）
1 期
0.1% topical sirolimus in the treatment of cutaneous microcystic lymphatic malformations in children and adults: phase II, split-body randomized, double-blind, vehicle-controlled clinical trialCutaneous microcystic lymphatic malformations (CMLM) in children and adultsMedDRA version: 20.0 Level: LLT Classification code 10003229 Term: Arteriovenous malformations System Organ Class: 100000004850EUCTR2018-001359-11-FRCHRU TOURS55
尚未招募
1 期
Efficacy and Safety of Topical Cyclosporine 0.05% and Lifitgrast on the Ocular Surface Symptom After Photorefractive Keratectomy in Feiz Hospital, Isfahan, 2024Ocular Surface SymptomOcular Surface DiseaseEye PainEye InflammationNCT06624384Mohsen Pourazizi150
进行中（未招募）
1 期
Topical Capsaicin 0.025% as a treatment for Achilles tendinopathy. A prospective, double blinded, randomised controlled trial with multiple outcome measures.Achilles TendinopathyEUCTR2006-005471-18-GBSheffield Teaching Hospitals NHS Foundation Trust